Publications

Article scientifiques

IMIG Pathology Panel: Husain AN, Borczuk A, Cagle P, Churg A, Colby T, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Krausz T, Litzky L, Ordonez N, Travis WD. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. (article accepté)

Dacic S, Kothmaier H, Land S, Shuai Y, Halbwedl I, Morbini P, Murer B, Comin C, Galateau-Salle F, Demirag F, Zeren H, Attanoos R, Gibbs A, Cagle P, Popper H. Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas. Virchows Arch 2008; 453:627–635.

Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique; 2008 Jun 9

Kothmaier H, Quehenberger F, Halbwedl I, Morbini P, Demirag F, Zeren H, Comin CE,Murer B, Cagle PT, Attanoos R, Gibbs AR, Galateau-Salle F, Popper HH. EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors. Thorax. 2008;63:345-51.

Letourneux M, Paris C, Pommier De Santi P, Clin B, Marquignon MF, Galateau-Sallé F. Benign asbestos-related pleuropulmonary diseases. Rev Mal Respir. 2007 Dec;24(10):1299-313.

Gilg soit Ilg A, Chamming’s S, Rolland P, Ducamp S, pochard P, Galateau-Sallé F, Pairon JC, Astoul P, de Quillac A, Frenay C, Goldberg M, Imbernon E. Programme national de surveillance du mésotheliome (PNSM) : principaux résultats, France, 1998-2004. Bull Epidémio Hebdo 2007, 41-42 :350-54.

Vignaud JM, Sabourin JC, Barnoud AL, Copin MC, Devouassoux-Shisheborn M, Galateau-Salle F, Moreno-Swirc S, Noël JC. Pathology of pleural and peritoneal serosa. Ann Pathol. 2007;27:195.

Weinpeck N, Vignaud JM, Begueret H, Burke L, Benhattar J, Guillou L, Capron F, Galateau-Salle F. SYT-SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleura. Mod Pathol. 2007 20:617-21.

Galateau-Sallé F, Attanoos R, Gibbs AR, Burke L, Astoul P, Rolland P, Ilg AG, Pairon JC, pochard P, Begueret H, Vignaud JM, Kerr K, Launoy G, Imbernon E, Goldberg M. Lymphohistiocytoid variant of malignant mesothelioma of the pleura: a series of 22 cases. Am J Surg Pathol. 2007 ;31:711-6.

Le Neindre B, Bouvier V, Galateau-Sallé F, de Quillacq A, Launoy G, Letourneux M. Compensation of malignant mesothelioma as an occupational disease in Lower Normandy, from 1995 to 2002. Rev Epidemiol Sante Publique. 2007 ;55123-31.

Geoffroy-Perez B, Imbernon E, Gilg Soit Ilg A, Goldberg. M. Confrontation des données du Programme national de surveillance du mésothéliome (PNSM) et du Programme de médicalisation du système d'information (PMSI). Rev Epid Santé Publ, 2006 ; 54:475-83.

Pairon JC, Fournier M, Astoul P, Galateau-Sallé F, pochard P. Medical-social aspects of pleural mesothelioma. Rev Mal Respir. 2006 ; 23(4 Pt 3):11S101-4.

Galateau-Sallé F, Copin MC, Delajartre AY, Vignaud JM, Astoul P, Pairon JC, Le Pimpec-Barthes F, pochard P. Which criteria for the anatomopathologic diagnosis of malignant pleural mesothelioma? Rev Mal Respir. 2006 ;23(4 Pt 3):11S37-44.

Pairon JC, Jaurand MC, Laurent F, Salmi R, Astoul P, Galateau-Sallé F, pochard P. How to assess asbestos exposure and identify a population at risk? Rev Mal Respir. 2006 23(4 Pt 3):11S9-27.

Andino L, Cagle PT, Murer B, Lu L, Popper HH, Galateau-Salle F, Sienko AE, Barrios R, Zander DS. Pleuropulmonary desmoid tumors: immunohistochemical comparison with solitary fipous tumors and assessment of beta-catenin and cyclin D1 expression. Arch Pathol Lab Med. 2006 ;130:1503-9.

Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Savès M, de Quillacq A, Frenay C, Chamming's S, Arveux P, Boutin C, Launoy G, Pairon JC, Astoul P, Galateau-Sallé F, pochard P. The French National Mesothelioma Surveillance Program. Occup Environ Med. 2006 63:390-5. Epub 2006 Feb 9.

Galateau-Salle F, pambilla E, Cagle P, Churg A, Colby T, Hammar S, Hasleton P, Gibbs AR, Kouki I, Roggli V, Travis WD, Vignaud JM, Pathology of Malignant mesothelioma; an update of the International Mesothelioma Panel in: Galateau –Sallé F, London, Springer Verlag 2006.

Galateau-Sallé F, Vignaud JM, Burke L, Gibbs A, pambilla R, Attanoos R, Goldberg M, Launoy G. Well- Differentiated Mesothelioma of the Pleura. Am J Surg Pathol. 2004;28:534-40.

Rihn BH, Mohr S, McDowell SA, Binet S, Loubinoux J, Galateau F, Keith G, Leikauf GD. Differential gene expression in mesothelioma. FEBS Lett. 2000 1;480:95-100.

Rapports, notes et ouvrages

Le Stang N, Molinié F, Galateau-Sallé F, Launoy G. Commentaires de la fiche plèvre. Mise en ligne en février 2008 sur le site de InVS. http://www.invs.sante.fr/surveillance/cancers/estimations_cancers/default.htm

Galateau-Sallé F, Cagle P. Non malignant versus malignant proliferations on pleural biopsy. In Diagnostic Pulmonary Pathology . Eds P.T.Cagle. Marcel Dekker New York. 2nd version. 2007.

Galateau-Sallé F, Vignaud.JM. Diffuse malignant mesothelioma. Genetic pathways, mechanisms of oncogenesis and other agents that cause mesotheliomas. Molecular Pathology of Lung Diseases to be edited by Philip Cagle, Dani S. Zander, Jaishree Jagirdar, Roberto Barrios, Abida Haque and Helmut Popper Springer Verlag. New York, 2007.

Galateau-Sallé F, Astoul P, Chammings' S, pochard P, Gilg Soit Ilg A, Launoy G, Pairon JC, Rolland P, Goldberg M, Imbernon E. Anatomie pathologie du mésothéliome pleural. In : Astoul P (Ed) Le mésothéliome pleural. Paris, Elsevier, 2005 : 89-107